Pacific Biosciences is trading 10.16% up at $1.35, with the move appearing primarily sector-driven as biotechnology stocks rally alongside positive clinical-news momentum.
- No clear company-specific announcement was identified for August 21, 2026.
- The latest official PacBio releases concern its August 5 leadership transition, quarterly results, and product updates, rather than a new catalyst today.